DOW vs FOLD · P/E 74, rev $42.96B vs rev $528.3M
Dow Inc (DOW) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the DOW and FOLD stock pages for the full models.
Not investment advice.